Physician

Sudhathi Chichili, M.D.

According to 2025 Medicare claims, Sudhathi Chichili, M.D. (NPI: 1730394891) practices hematology/oncology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Contra Costa, CA. This provider's primary affiliated billing organization is EPIC CARE (NPI: 1780107797; TIN: 821993796) and primary practice location at 94523-2163. Chichili is affiliated with the Aledade 147 Hill Physicians MSSP Basic E (ACO ID: A5230), participating under the MSSP model.

Chichili's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 405 traditional Medicare patients, billed 89,186 HCPCS/CPT codes, and received $1,706,361 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 754 prescription claims across 110 beneficiaries totaling $1,580,732 in drug costs, led by Idhifa (Enasidenib Mesylate). DME data shows 48 claims. Open Payments data shows 178 records totaling $4,285. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $45,791 to $1,706,361. Similarly, Part D prescription costs have risen steadily, from $9,294 to $1,580,732. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	78	9,137	$45,791
2018	248	36,437	$244,360
2019	203	34,689	$187,483
2020	262	28,457	$482,061
2021	532	73,787	$1,156,409
2022	583	107,743	$1,062,366
2023	341	92,856	$1,068,644
2024	405	89,186	$1,706,361

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	102	215	$9,294
2016	280	2,847	$138,320
2017	179	1,851	$196,896
2018	121	578	$544,878
2019	55	270	$398,577
2020	48	424	$970,234
2021	75	451	$1,217,512
2022	81	555	$1,489,950
2023	94	566	$1,635,913
2024	110	754	$1,580,732

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$432
2023	N/R	24	$649
2024	N/R	48	$1,013

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	124	228	$168
99443	Telephone medical discussion with physician, 21-30 minutes	153	306	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	121	182	$119
36415	Insertion of needle into vein for collection of blood sample	123	596	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	102	421	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Idhifa	Enasidenib Mesylate	11	330	$372,444
Lenalidomide	Lenalidomide	12	336	$156,724
Eliquis	Apixaban	40	1,530	$28,317
Imatinib Mesylate	Imatinib Mesylate	13	422	$7,846
Exemestane	Exemestane	14	1,115	$2,021

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8700	Temozolomide, oral, 5 mg	N	N/R	15	$516
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	22	$290
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	178	$4,285	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sudhathi Chichili, M.D.?

Tedicare shows public-source Medicare data for Sudhathi Chichili, M.D. (NPI 1730394891), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sudhathi Chichili, M.D. have ACO affiliation data?

Sudhathi Chichili, M.D. is shown with ACO affiliation data for Aledade 147 Hill Physicians MSSP Basic E (MSSP, ACO ID A5230).

What billing organization is linked to Sudhathi Chichili, M.D.?

Sudhathi Chichili, M.D. is linked to EPIC CARE (billing NPI 1780107797) in the available physician profile data.

Does Sudhathi Chichili, M.D. have Open Payments data?

Sudhathi Chichili, M.D. has 178 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.